The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multicenter observational study on adherence and acceptance of lapatinib treatment in patients with HER2+ metastatic breast cancer.
R. Addeo
No relevant relationships to disclose
B. Vincenzi
No relevant relationships to disclose
F. Riccardi
No relevant relationships to disclose
A. Febbraro
No relevant relationships to disclose
L. Maiorino
No relevant relationships to disclose
P. Incoronato
No relevant relationships to disclose
R. Mabilia
No relevant relationships to disclose
M. Bianco
No relevant relationships to disclose
E. Russo
No relevant relationships to disclose
A. Pisano
No relevant relationships to disclose
S. Del Prete
No relevant relationships to disclose